Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32598977.
- Also identified by DOI 10.1016/j.radonc.2020.06.040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibroblast Activation Protein (FAP)-specific Positron Emission Tomography (PET) has shown promising results in various cancers. This pilot study compares FAP-specific PET to MRI for treatment planning in 13 Glioblastoma patients. The resulting incongruent volumes could provide additional information for radiotherapy or biopsy planning.
Medical subject headings
- Brain Neoplasms
- Glioblastoma